Received May 15, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | UNK | 3043838 | IM |
Patient experienced arm pain after receiving the Moderna vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of PAIN IN EXTREMITY (Patient experienced arm pain after receiving the Moderna vaccine) in a patient of an unknown age and gender who received mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) (batch no. 3043838) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) (Intramuscular use) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Patient experienced arm pain after receiving the Moderna vaccine). At the time of the report, PAIN IN EXTREMITY (Patient experienced arm pain after receiving the Moderna vaccine) outcome was unknown. For mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) (Intramuscular use), the reporter did not provide any causality assessments. No concomitant medication was reported. It was unknown if the patient experienced any additional symptoms/events. The reporter checked to see if Spikevax lot 2043838 had any quality issues or concerns. No treatment medication was reported. This case contains information for the 3rd patient out of 5 patients. This case was linked to US-MODERNATX, INC.-MOD-2025-786107 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 07-May-2025: Live Follow up received that contains non-significant information: Reference added. On 07-May-2025: Live Follow up received that contains non-significant information: Reference added.; Sender's Comments: US-MODERNATX, INC.-MOD-2025-786107:Master case